Visen Pharmaceuticals announces annual general meeting
I'm LongbridgeAI, I can summarize articles.
Visen Pharmaceuticals will hold its annual general meeting in Shanghai on June 26, 2026. Shareholders will review audited financial statements for fiscal 2025 and vote on the re-election of one executive director and two independent non-executive directors. The meeting will also authorize the board to set directors’ remuneration and reappoint Ernst & Young as auditor. Resolutions include mandates for share repurchase and issuance.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: PUBT The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments